Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Radiology
Published in: European Radiology 8/2020

01-08-2020 | Biliary Tract Diseases | Vascular-Interventional

Absorbable stents for treatment of benign biliary strictures: long-term follow-up in the prospective Spanish registry

Authors: Miguel A. De Gregorio, Eva Criado, Jose A. Guirola, Enrique Alvarez-Arranz, Mercedes Pérez-Lafuente, Marta Barrufet, Maria D. Ferrer-Puchol, Sandra Lopez-Minguez, Jose Urbano, Carlos Lanciego, Alexander Aguinaga, Antonio Capel, Maria D. Ponce-Dorrego, Abel Gregorio, Spanish group BiELLA (SERVEI)

Published in: European Radiology | Issue 8/2020

Login to get access

Abstract

Objectives

Benign strictures of the bile duct may be difficult to treat endoscopically due to altered bowel anatomy. Furthermore, recurrence of stenosis and symptoms remains high. The aim of the Spanish Prospective Registry BiELLA study was to investigate the safety and efficacy of absorbable stents in the treatment of benign biliary strictures and their outcomes on the medium and long-term follow-up.

Methods

A prospective, multicenter, observational, non-randomized study (the BiELLA study) was conducted from January 2014 to September 2018. One hundred fifty-nine patients with benign biliary strictures, mostly postsurgical, were enrolled for implantation of absorbable biliary stents in the 11 participating Spanish tertiary hospitals. The average patient follow-up was 45.4 ± 15.9 months (range, 12–60 months). The follow-up data included symptoms, biochemical parameters, and ultrasound images at 1, 6, and 12 months and then yearly for up to 60 months.

Results

The immediate technical and clinical success rates were 100%. In all patients, stent placement resulted in improvement of clinical symptoms and biochemical parameters. The primary mean patency for stent was 86.7, 79.6, and 78.9% at 12, 36, and 60 months, respectively (95% CI). Biliary restenosis and occlusion occurred in 40 (26.6%) patients. Of the 40 patients, 18 (12%) patients were treated with a second stent and 22 (14.6%) patients had operative repair of the recurrent strictures. There were no major complications associated with stent implantation.

Conclusions

Implantation of an absorbable polydioxanone biliary stent is safe and effective for treatment of benign biliary strictures refractory to balloon dilatation or other biliary intervention.

Key Points

• Percutaneous implantation of biodegradable prostheses for the treatment of benign postsurgical biliary strictures is a safe and effective procedure.
• More than 75% of the patients presented patency of the stented biliary tree at 5 years follow-up.
• Absorbable stents improved clinical symptoms and signs (jaundice, itching, fever), and laboratory parameters in a few days after stent placement.
Literature
1.
Dimou FM, Adhikari D, Mehta HB, Olino K, Riall TS, Brown KM (2016) Incidence of hepaticojejunostomy stricture following hepaticojejunostomy. Surgery 160:691–698PubMedPubMedCentral
2.
Ahrendt SA, Pitt HA (2001) Surgical therapy of iatrogenic lesions of biliary tract. World J Surg 25:1360–1365PubMed
3.
Strasberg SM, Picus DD, Drebin JA (2001) Results of a new strategy for reconstruction of biliary injuries having an isolated right-sided component. J Gastrointest Surg 5:266–274PubMed
4.
Lillemoe KD, Petrofski JA, Choti MA, Venbrux AC, Cameron JL (2000) Isolated right segmental hepatic injury: a diagnostic and therapeutic challenge. J Gastrointest Surg 2:168–177
5.
Mercado MA, Chan C, Orozco H, Tielve M, Hinojosa CA (2003) Acute bile duct injury. Surg Endosc 17:1351–1355
6.
Mercado MA, Orozco H, De la Garza L, López-Martínez LM, Contreras A , Guillén-Navarro E (1999) Biliary duct injury: partial segment IV resection for intrahepatic reconstruction of biliary lesions. Arch Surg 134:1008–1010
7.
Lillemoe KD, Pitt HA, Cameron JL (1992) Current management of benign bile duct strictures. Adv Surg 25:119–174PubMed
8.
Lillemoe KD (1997) Benign postoperative bile duct strictures. Baillieres Clin Gastroenterol 11:749–779PubMed
9.
10.
Kapoor BS, Mauri G, Lorenz JM (2018) Management of biliary strictures: state-of-the-art review. Radiology 289:590–603PubMed
11.
Baron TH, Davee T (2012) Endoscopic management of benign bile duct strictures. Gastrointest Endosc Clin N Am 23:295–311
12.
Kim JH, Gwon D II, Ko G-Y et al (2011) Temporary placement of retrievable fully covered metallic stents versus percutaneous balloon dilation in the treatment of benign biliary strictures. J Vasc Interv Radiol 22:893–899PubMed
13.
Irani S, Baron TH, Akbar A et al (2014) Endoscopic treatment of benign biliary strictures using covered self-expandable metal stents (CSEMS). Dig Dis Sci 59:152–160PubMed
14.
Ludwig JM, Webber GR, Knechtle SJ, Spivey JR, Xing M, Kim HS (2016) Percutaneous management of benign biliary strictures with large-bore catheters: comparison between patients with and without orthotopic liver transplantation. J Vasc Interv Radiol 27:219–225PubMed
15.
Gwon D II, Ko G-Y, Ko HK, Yoon H-K, Sung K-B (2013) Percutaneous transhepatic treatment using retrievable covered stents in patients with benign biliary strictures: mid-term outcomes in 68 patients. Dig Dis Sci 58:3270–3279PubMed
16.
Moraca RJ, Lee F, Ryan JA Jr, Traverso LW (2002) Long term biliary function after reconstruction of major bile duct injuries with hepaticoduodenostomy or hepaticojejunostomy. Arch Surg 137:889–893PubMed
17.
Melton GB, Lillemoe KD (2002) The current management of postoperative bile duct strictures. Adv Surg 36:193–221PubMed
18.
Kalinowski M, Alfke H, Kleb B, Dürfeld F, Joachim Wagner H (2002) Paclitaxel inhibits proliferation of cell lines responsible for metal stent obstruction: possible topical application in malignant bile duct obstructions. Invest Radiol 37:399–404PubMed
19.
Mauri G, Michelozzi C, Melchiorre F et al (2013) Biodegradable biliary stent implantation in the treatment of benign bilioplastic-refractory biliary strictures: preliminary experience. Eur Radiol 23:3304–3310PubMed
20.
Mauri G, Michelozzi C, Melchiorre F et al (2016) Benign biliary strictures refractory to standard bilioplasty treated using polydoxanone biodegradable biliary stents: retrospective multicentric data analysis on 107 patients. Eur Radiol 26:4057–4063 13PubMed
21.
Petrtýl J, Brůha R, Horák L, Zádorová Z, Dosedel J, Laasch HU (2010) Management of benign intrahepatic bile duct strictures: initial experience with polydioxanone biodegradable stents. Endoscopy 42:E89–E90PubMed
22.
Dopazo C, Diez I, Quintero J et al (2018) Role of biodegradable stents as part of treatment of biliary strictures after pediatric and adult liver transplantation: an observational single-center study. J Vasc Interv Radiol 29:899–904PubMed
23.
Vondrys D, Elliott MJ, McLaren CA, Noctor C, Roebuck DJ (2011) First experience with biodegradable airway stents in children. Ann Thorac Surg 92:1870–1874 24PubMed
24.
Janík V, Horák L, Hnaníček J, Málek J, Laasch HU (2011) Biodegradable polydioxanone stents: a new option for therapy resistant anastomotic strictures of the colon. Eur Radiol 21:1956–1961PubMed
25.
Stivaros SM, Williams LR, Senger C, Wilbraham L, Laasch HU (2010) Woven polydioxanone biodegradable stents: a new treatment option for benign and malignant oesophageal strictures. Eur Radiol 20:1069–1072PubMed
26.
Shi J, Lv Y, Yu L et al (2013) Interest of a new biodegradable stent coated with paclitaxel on anastomotic wound healing after biliary reconstruction. Eur J Gastroenterol Hepatol 25:1415–1423PubMed
27.
Yamamoto K, Yoshioka T, Furuichi K et al (2011) Experimental study of poly- L-lactic acid biodegradable stents in normal canine bile ducts. Cardiovasc Intervent Radiol 34:601–608PubMed
28.
Mauri G, Criado E (2016) Percutaneous management of benign biliary strictures: is it time to focus on reducing procedure invasiveness? J Vasc Interv Radiol 27:934–936PubMed
29.
von Elm E, Altman DG, Egger M et al (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61:344–349CrossRef
30.
Khan M, Baron T, Kamal F et al (2017) Efficacy of self-expandable metal stents in management of benign biliary strictures and comparison with multiple plastic stents: a meta-analysis. Endoscopy 49:682–694PubMed
31.
Shimada H, Endo I, Shimada K, Matsuyama R, Kobayashi N, Kubota K (2012) The current diagnosis and treatment of benign biliary stricture. Surg Today 42:1143–1153PubMed
32.
33.
Zepeda-Gómez S, Baron TH (2011) Benign biliary strictures: current endoscopic management. Nat Rev Gastroenterol Hepatol 8:573–581PubMed
34.
Garcia-Cano J (2012) Use of fully covered self-expanding metal stents in benign biliary diseases. World J Gastrointest Endosc 4:142–147PubMedPubMedCentral
35.
van Boeckel PGA, Vleggaar FP, Siersema PD (2009) Plastic or metal stents for benign extrahepatic biliary strictures: a systematic review. BMC Gastroenterol 9:96PubMedPubMedCentral
36.
Cozzaglio L, Cimino M, Mauri G et al (2011) Percutaneous transhepatic biliary drainage and occlusion balloon in the management of duodenal stump fistula. J Gastrointest Surg 15:1977–1981PubMed
37.
Pedicini V, Poretti D, Mauri G et al (2010) Management of post-surgical biliary leakage with percutaneous transhepatic biliary drainage (PTBD) and occlusion balloon (OB) in patients without dilatation of the biliary tree: preliminary results. Eur Radiol 20:1061–1068PubMed
38.
Yano T, Yoda Y, Nomura S et al (2017) Prospective trial of biodegradable stents for refractory benign esophageal strictures after curative treatment of esophageal cancer. Gastrointest Endosc 86:492–499PubMed
39.
Sigounas DE, Siddhi S, Plevris JN (2016) Biodegradable esophageal stents in benign and malignant strictures - a single center experience. Endosc Int Open 4:E618–E623PubMedPubMedCentral
40.
Köcher M, Cerná M, Havlík R, Král V, Gryga A, Duda M (2007) Percutaneous treatment of benign bile duct strictures. Eur J Radiol 62:170–174PubMed
41.
Atar E, Bachar GN, Bartal G et al (2005) Use of peripheral cutting balloon in the management of resistant benign ureteral and biliary strictures. J Vasc Interv Radiol 16:241–245PubMed
42.
Dhondt E, Vanlangenhove P, Van Vlierberghe H et al (2019) Benign anastomotic biliary strictures untreatable by ERCP: a novel percutaneous balloon dilatation technique avoiding indwelling catheters. Eur Radiol 29:636–644PubMed
43.
Grolich T, Crha M, Novotný L et al (2015) Self-expandable biodegradable biliary stents in porcine model. J Surg Res 193:606–612PubMed
44.
ASGE Technology Committee, Tokar JL, Banerjee S et al (2011) Drugeluting/ biodegradable stents. Gastrointest Endosc 74:954–958
45.
Siiki A, Rinta-Kiikka I, Sand J, Laukkarinen J (2018) A pilot study of endoscopically inserted biodegradable biliary stents in the treatment of benign biliary strictures and cystic duct leaks. Gastrointest Endosc 87:1132–1137PubMed
46.
Siiki A, Sand J, Laukkarinen J (2018) A systematic review of biodegradable biliary stents: promising biocompatibility without stent removal. Eur J Gastroenterol Hepatol 30:813–818PubMed
47.
Lorenzo-Zúñiga V, Moreno-de-Vega V, Marín I, Boix J (2014) Biodegradable stents in gastrointestinal endoscopy. World J Gastroenterol 20:2212–2217PubMedPubMedCentral
Metadata
Title
Absorbable stents for treatment of benign biliary strictures: long-term follow-up in the prospective Spanish registry
Authors
Miguel A. De Gregorio
Eva Criado
Jose A. Guirola
Enrique Alvarez-Arranz
Mercedes Pérez-Lafuente
Marta Barrufet
Maria D. Ferrer-Puchol
Sandra Lopez-Minguez
Jose Urbano
Carlos Lanciego
Alexander Aguinaga
Antonio Capel
Maria D. Ponce-Dorrego
Abel Gregorio
Spanish group BiELLA (SERVEI)
Publication date
01-08-2020
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 8/2020
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-020-06797-7

Other articles of this Issue 8/2020

European Radiology 8/2020 Go to the issue

Cardiac

Cardiovascular magnetic resonance–derived myocardial strain in asymptomatic heart transplanted patients and its correlation with late gadolinium enhancement

Urogenital

Protocol analysis of dual-energy CT for optimization of kidney stone detection in virtual non-contrast reconstructions

Breast

Digital zoom of the full-field digital mammogram versus magnification mammography: a systematic review

Interventional

Contrast-enhanced ultrasound–guided celiac plexus neurolysis in patients with upper abdominal cancer pain: initial experience

Head and Neck

Chronic invasive fungal rhinosinusitis vs sinonasal squamous cell carcinoma: the differentiating value of MRI

Gastrointestinal

Meglumine diatrizoate esophagogram after peroral endoscopic myotomy (POEM): identification of imaging findings associated with clinical complications and longer hospital stay